Coya Therapeutics has announced the acceptance by the US FDA of IND application for COYA 302, paving the way for a Phase II ...

BlossomHill Therapeutics has dosed the first subject in the expansion cohorts of the SOLARA Phase I/II trial to evaluate ...

Lighthouse secured a grant of $49.2m from the National Institute on Aging (NIA) to facilitate study of LHP588 for Alzheimer's ...